AMANDA MUNDEN: Open Payments
NPI 1063197341 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 10 payments from 6 companies in 2025. Trend: 2023 $87 · 2024 $216 · 2025 $466
Food & beverage: $367Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $157 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Astellas Pharma US Inc | 2 | $121 |
| ABBVIE INC. | 1 | $29 |
| Organon LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, AIRSUPRA, QULIPTA, Veozah, NEXPLANON, MOUNJARO.
Industry payments across FL — which companies pay providers there.
